| Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy E Lonardo, PC Hermann, MT Mueller, S Huber, A Balic, ... Cell stem cell 9 (5), 433-446, 2011 | 465 | 2011 |
| Intracellular autofluorescence: a biomarker for epithelial cancer stem cells I Miranda-Lorenzo, J Dorado, E Lonardo, S Alcala, AG Serrano, ... Nature methods 11 (11), 1161-1169, 2014 | 237 | 2014 |
| TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression S Ottaviani, J Stebbing, AE Frampton, S Zagorac, J Krell, A de Giorgio, ... Nature communications 9 (1), 1845, 2018 | 127 | 2018 |
| DNMT1 inhibition reprograms pancreatic cancer stem cells via upregulation of the miR-17-92 cluster S Zagorac, S Alcala, G Fernandez Bayon, T Bou Kheir, M Schoenhals, ... Cancer research 76 (15), 4546-4558, 2016 | 112 | 2016 |
| Circulating microRNAs in small-bowel neuroendocrine tumors: a potential tool for diagnosis and assessment of effectiveness of surgical resection A Malczewska, AE Frampton, MM Prado, S Ameri, AF Dabrowska, ... Annals of surgery 274 (1), e1-e9, 2021 | 36 | 2021 |
| SCIRT lncRNA restrains tumorigenesis by opposing transcriptional programs of tumor-initiating cells S Zagorac, A de Giorgio, A Dabrowska, M Kalisz, N Casas-Vila, ... Cancer Research 81 (3), 580-593, 2021 | 26 | 2021 |
| GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma MP de Andrés, RJ Jackson, I Felipe, S Zagorac, C Pilarsky, AM Schlitter, ... Gut 72 (3), 535-548, 2023 | 25 | 2023 |
| Managing patients with cancer in the COVID-19 era L Peng, S Zagorac, J Stebbing European Journal of cancer 132, 5-7, 2020 | 24 | 2020 |
| Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities B Caramelo, S Zagorac, S Corral, M Marqués, FX Real European Urology Oncology 6 (4), 366-375, 2023 | 21 | 2023 |
| Bcl3 couples cancer stem cell enrichment with pancreatic cancer molecular subtypes J Ai, SM Wörmann, K Görgülü, M Vallespinos, S Zagorac, S Alcala, N Wu, ... Gastroenterology 161 (1), 318-332. e9, 2021 | 14 | 2021 |
| The mutational landscape of the adult healthy parous and nulliparous human breast B Cereser, A Yiu, N Tabassum, L Del Bel Belluz, S Zagorac, KRZ Ancheta, ... Nature Communications 14 (1), 5136, 2023 | 11 | 2023 |
| The epigenetic landscape of pancreatic cancer stem cells S Zagorac, L Garcia-Bermejo, B Sainz Jr Epigenomes 2 (2), 10, 2018 | 10 | 2018 |
| Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma B Parejo-Alonso, A Royo-García, P Espiau-Romera, S Courtois, ... Biomedicine & Pharmacotherapy 158, 114162, 2023 | 7 | 2023 |
| Mutational landscapes of normal breast during age and pregnancy determine cancer risk B Cereser, N Tabassum, LDB Belluz, A Yiu, S Zagorac, C Miere, B Werner, ... bioRxiv, 2020.09. 04.277715, 2020 | 3 | 2020 |
| MicroRNA-mRNA interactions controlled by TGF-b S Ottaviani, AF Frampton, M Chugh, P Dama, T Stiff, Q Liu, S Bayraktar, ... Pancreatology 20 (8), e17, 2020 | 1 | 2020 |
| Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression S Ottaviani, J Stebbing, AE Frampton, S Zagorac, J Krell, A de Giorgio, ... Nature Communications 10, 3738, 2019 | 1 | 2019 |
| Identification and functional characterization of epigenetic determinants of pancreatic CSCs S Zagorac PhD dissertation, la Universidad Autónoma de Madrid, 11–16–2015, 2015 | 1 | 2015 |
| Vitamin D and pancreatic cancer EL de Maturana, S Zagorac, N Malats, FX Real Feldman and Pike's Vitamin D, 937-966, 2024 | | 2024 |
| ALK signaling drives tumorigenicity and chemoresistance of pancreatic ductal adenocarcinoma cells B Parejo-Alonso, A Royo-García, P Espiau-Romera, S Courtois, ... bioRxiv, 2022.08. 29.505637, 2022 | | 2022 |
| Abstract PD5-10: Mutational burden of the normal breast during age and pregnancy B Cereser, N Tabassum, L Del Bel Belluz, S Zagorac, A Yiu, P Carter, ... Cancer Research 81 (4_Supplement), PD5-10-PD5-10, 2021 | | 2021 |